As of Aug 26
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a -6.25% decrease from the last price of 1.60.
The current consensus among 2 polled investment analysts is to Hold stock in Aegerion Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.